Avitas Wealth Management LLC Grows Stock Position in CME Group Inc (NASDAQ:CME)

Avitas Wealth Management LLC increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 1.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,692 shares of the financial services provider’s stock after buying an additional 354 shares during the quarter. CME Group comprises approximately 1.3% of Avitas Wealth Management LLC’s portfolio, making the stock its 12th biggest holding. Avitas Wealth Management LLC’s holdings in CME Group were worth $4,796,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Advantage Investment Management LLC lifted its position in CME Group by 119.0% during the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after buying an additional 100 shares during the period. Westside Investment Management Inc. purchased a new position in CME Group during the second quarter worth about $38,000. Private Capital Group LLC increased its stake in CME Group by 44.9% during the second quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 75 shares during the last quarter. Garrett Wealth Advisory Group LLC acquired a new stake in CME Group during the third quarter worth about $42,000. Finally, Motco increased its stake in CME Group by 55.8% during the second quarter. Motco now owns 268 shares of the financial services provider’s stock worth $52,000 after acquiring an additional 96 shares during the last quarter. Hedge funds and other institutional investors own 84.92% of the company’s stock.

Several equities research analysts have commented on the company. UBS Group upped their price target on CME Group from $214.00 to $220.00 and gave the stock a “neutral” rating in a research note on Thursday, October 3rd. Berenberg Bank lowered CME Group from a “buy” rating to a “hold” rating and dropped their price target for the stock from $236.00 to $227.00 in a research note on Thursday, September 19th. ValuEngine lowered CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Wells Fargo & Co upped their price target on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research note on Wednesday, July 3rd. Finally, BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a research note on Friday. Three analysts have rated the stock with a sell rating, eight have given a hold rating and six have given a buy rating to the company. CME Group presently has a consensus rating of “Hold” and an average target price of $200.43.

In related news, insider Sean Tully sold 7,200 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $223.13, for a total value of $1,606,536.00. Following the completion of the transaction, the insider now owns 19,923 shares of the company’s stock, valued at $4,445,418.99. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $200.15, for a total value of $7,005,250.00. Following the completion of the transaction, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,126 shares of company stock valued at $11,752,684. Insiders own 1.20% of the company’s stock.

CME stock opened at $213.17 on Friday. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.05 and a current ratio of 1.05. CME Group Inc has a 1 year low of $161.05 and a 1 year high of $224.91. The firm has a market cap of $76.28 billion, a P/E ratio of 32.27, a price-to-earnings-growth ratio of 4.51 and a beta of 0.20. The stock has a 50-day simple moving average of $213.58 and a 200-day simple moving average of $198.37.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the firm earned $1.74 earnings per share. The company’s revenue for the quarter was up 20.1% compared to the same quarter last year. On average, equities research analysts predict that CME Group Inc will post 6.79 EPS for the current year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th were paid a $0.75 dividend. The ex-dividend date was Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.41%. CME Group’s dividend payout ratio (DPR) is currently 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: How are institutional investors different from individual investors?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.